Humana (HUM) Stock Forecast, Price & News

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HUM shares.
View HUM analyst ratings or view top-rated stocks.

16 Wall Street analysts have issued 1-year price objectives for Humana's stock. Their HUM share price forecasts range from $540.00 to $652.00. On average, they expect the company's share price to reach $591.89 in the next year. This suggests a possible upside of 19.8% from the stock's current price.
View analysts price targets for HUM or view top-rated stocks among Wall Street analysts.

Humana's stock was trading at $512.19 at the beginning of the year. Since then, HUM shares have decreased by 3.6% and is now trading at $493.91.
View the best growth stocks for 2023 here.

Humana saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 3,060,000 shares, an increase of 41.0% from the June 30th total of 2,170,000 shares. Based on an average trading volume of 1,340,000 shares, the days-to-cover ratio is presently 2.3 days. Approximately 2.5% of the company's shares are short sold.
View Humana's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our HUM earnings forecast.

Humana Inc. (NYSE:HUM) released its earnings results on Wednesday, August, 2nd. The insurance provider reported $8.94 earnings per share for the quarter, beating the consensus estimate of $8.88 by $0.06. The insurance provider earned $26.75 billion during the quarter, compared to the consensus estimate of $25.83 billion. Humana had a net margin of 3.42% and a trailing twelve-month return on equity of 20.70%. The firm's revenue was up 13.0% on a year-over-year basis. During the same period in the prior year, the business posted $8.67 earnings per share.
Read the conference call transcript.

Humana declared a quarterly dividend on Thursday, April 20th. Shareholders of record on Friday, June 30th will be given a dividend of $0.885 per share on Friday, July 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend is Thursday, June 29th.
Read our dividend analysis for HUM.

ETFs with the largest weight of Humana (NYSE:HUM) stock in their portfolio include Optimize AI Smart Sentiment Event-Driven ETF (OAIE), iShares U.S. Healthcare Providers ETF (IHF), Stance Equity ESG Large Cap Core ETF (STNC), First Trust Long/Short Equity ETF (FTLS), Alpha Intelligent - Large Cap Value ETF (AILV), Fidelity Disruptive Medicine ETF (FMED), First Trust Growth Strength ETF (FTGS) and American Customer Satisfaction ETF (ACSI).

Humana (NYSE:HUM) pays an annual dividend of $3.54 per share and currently has a dividend yield of 0.72%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 13.21%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

Humana updated its FY 2023 earnings guidance on Saturday, August, 5th. The company provided earnings per share guidance of $28.25- for the period, compared to the consensus estimate of $28.29. The company issued revenue guidance of -.

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana's stock is owned by many different institutional and retail investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (10.60%), Capital International Investors (3.12%), Capital World Investors (1.87%), Geode Capital Management LLC (1.85%), Capital Research Global Investors (1.22%) and Northern Trust Corp (1.02%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HUM stock can currently be purchased for approximately $493.91.

Humana (NYSE:HUM) has a market capitalization of $61.20 billion and generates $98.73 billion in revenue each year. The insurance provider earns $2.81 billion in net income (profit) each year or $26.80 on an earnings per share basis.

The company employs 67,100 workers across the globe.

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The official website for the company is www.humana.com. The insurance provider can be reached via phone at (502) 580-1000, via email at amysmith@humana.com, or via fax at 502-580-3639.